Skip to main content

Table 8 All ED visits by patients’ characteristics identified in the year they responded to the HCES

From: Comparing primary care Interprofessional and non-interprofessional teams on access to care and health services utilization in Ontario, Canada: a retrospective cohort study

 

HCES Respondents in Interprofessional Teams

HCES Respondents in Non-interprofessional Teams

≥1 ED visits

≥1 ED visits

Denominator

Weighted Percentage

Denominator

Weighted Percentage

Overall ED visits

12,988

26.7

11,648

23.5

Sex

 Males

5310

26.7

4792

22.9

 Female

7678

26.7

6856

23.9

 Missing

0

–

0

–

Age group, yr.

 16–44

3819

26.8

3653

22.3

 45–64

5272

24.1

4661

21.8

 65–84

3602

29.2

3071

26.1

 85+

295

40.0

263

38.4

 Missing

0

–

0

–

New OHIP registrants (within 10 years)

 Yes

355

20.3

460

22.0

 No

12,620

26.9

11,174

23.6

Income quintile

 1 (low)

2089

33.3

1764

27.7

 2

D/S

D/S

D/S

D/S

 3

2697

26.4

2295

23.8

 4

2822

24.8

2550

21.9

 5 (high)

2888

22.6

2784

21.6

 Missing

D/S

D/S

D/S

D/S

Rurality Index of Ontario

 Largest Urban (0)

3759

23.5

4000

20.9

 Large urban (1 to 9)

2388

22.0

4078

20.3

 Small-urban (10 to 39)

4823

27.8

2737

28.0

 Rural (≥40)

1892

35.3

763

37.5

 Missing

126

38.1

70

30.0

Resource utilization band (RUB)

 1

629

19.9

471

15.7

 2

2128

19.2

1802

15.2

 3

6746

25.7

6417

22.7

 4

2031

34.6

1869

31.7

 5 (very high user)

823

48.5

674

42.7

 Non-user and Missing

631

15.5

415

13.5

Patients with Chronic disease

 2 + Co-morbidity

  Yes

6096

32.0

5628

23.5

  No

6892

22.0

6020

23.5

 3+ comorbidities

  Yes

3482

36.4

3207

32.6

  No

9506

23.1

8441

20.0

 4+ comorbidities

  Yes

1828

40.6

1686

37.9

  No

11,160

24.4

9962

21.0

 5+ comorbidities

  Yes

894

47.0

791

41.6

  No

12,094

25.2

10,857

22.2

  1. D/S Data suppressed where counts are between 1 and 5; additional suppression may be applied where counts are greater than 5 to prevent residual disclosure of suppressed values—in compliant with the Personal Health Information Protection Act (PHIPA) privacy legislation